(0%) 0 points
(0%) 0 points
(0%) 0 points
(0%) $0
(0%) $0
(0%) $0
(0%) $0
(0%) $0
(0%) $0
(0%) $0
(0%) $0
(0%) $0
Live Chart Being Loaded With Signals
Predictive Oncology Inc., a knowledge-driven company, focuses on developing personalized cancer therapies using artificial intelligence (AI) primarily in the United States...
Stats | |
---|---|
本日の出来高 | 24 877.00 |
平均出来高 | 33 975.00 |
時価総額 | 5.63M |
EPS | $0 ( 2024-04-02 ) |
次の収益日 | ( $0 ) 2024-05-13 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.400 |
ATR14 | $0.0300 (2.17%) |
ボリューム 相関
Predictive Oncology Inc 相関
10 最も負の相関 |
---|
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
Predictive Oncology Inc 相関 - 通貨/商品
Predictive Oncology Inc 財務諸表
Annual | 2023 |
収益: | $1.78M |
総利益: | $433 407 (24.35 %) |
EPS: | $-3.48 |
FY | 2023 |
収益: | $1.78M |
総利益: | $433 407 (24.35 %) |
EPS: | $-3.48 |
FY | 2022 |
収益: | $1.51M |
総利益: | $1.00M (66.45 %) |
EPS: | $-9.92 |
FY | 2021 |
収益: | $1.42M |
総利益: | $933 656 (65.72 %) |
EPS: | $-1.645 |
Financial Reports:
No articles found.
Predictive Oncology Inc
Predictive Oncology Inc., a knowledge-driven company, focuses on developing personalized cancer therapies using artificial intelligence (AI) primarily in the United States. The company operates in four segments: Helomics, zPREDICTA, Soluble, and Skyline. The Helomics segment offers clinical testing services comprising tumor drug response testing and genomic profiling tests; and contract research services through patient-centric drug discovery using active learning technology for discovery, clinical and translational research, clinical trials, and diagnostic development and validation. The zPREDICTA segment develops organ-specific disease models that provide 3D reconstruction of human tissues representing each disease state and mimicking drug response for testing of anticancer agents. The Soluble segment provides services using High-Throughput Self-Interaction Chromatography, a self-contained, automated system that conducts high-throughput, self-interaction chromatography screens using additives and excipients that are included in protein formulations for soluble and physically stable formulations for biologics. This segment also offers protein stability analysis services; protein solubility kits that allow rapid identification of soluble formulations; and proprietary technologies for bacterial endotoxin detection and removal. The Skyline segment provides STREAMWAY System, a wall-mounted fully automated system, which virtually eliminates staff exposure to blood, irrigation fluid, and other infectious fluids found in the healthcare environment. It also offers research and development services; and media that help cancer cells grow outside the patient's body and retain their DNA/RNA and proteomic signatures. The company was formerly known as Precision Therapeutics Inc. and changed its name to Predictive Oncology Inc. in June 2019. Predictive Oncology Inc. was incorporated in 2002 and is based in Eagan, Minnesota.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。